Gene: DRD3
Official Full Name: dopamine receptor D3provided by HGNC
Gene Summary: This gene encodes the D3 subtype of the five (D1-D5) dopamine receptors. The activity of the D3 subtype receptor is mediated by G proteins which inhibit adenylyl cyclase. This receptor is localized to the limbic areas of the brain, which are associated with cognitive, emotional, and endocrine functions. Genetic variation in this gene may be associated with susceptibility to hereditary essential tremor 1. Alternative splicing of this gene results in transcript variants encoding different isoforms, although some variants may be subject to nonsense-mediated decay (NMD). [provided by RefSeq, Jul 2008]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA16179 | DRD3 Knockout cell line (AC16) | Human | DRD3 | 1:3-1:4 | negative | Online Inquiry |
| KOA31626 | DRD3 Knockout cell line (BEAS-2B) | Human | DRD3 | 1:3~1:4 | negative | Online Inquiry |
| KOA47043 | DRD3 Knockout cell line (U-2932) | Human | DRD3 | 1:2-1:4 | negative | Online Inquiry |
| KOA62440 | DRD3 Knockout cell line (TPC-1) | Human | DRD3 | 1:5-1:8 | negative | Online Inquiry |
| KOA77865 | DRD3 Knockout cell line (NCM460) | Human | DRD3 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.